2010 Annual Meeting | Neuromuscular Junction Disorders

Date Sunday 04/11/10

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Janice M. Massey, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish among the various types of congenital myasthenic syndromes.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
09:00 AM - 09:10 AM		Introduction Janice M. Massey, MD, FAAN
09:10 AM - 09:45 AM		Clinical Assessment Tools in the Diagnosis and Management of Myasthenia Gravis Ted M. Burns, MD
09:45 AM - 10:20 AM		Is There A Role for Thymectomy in Myasthenia Gravis? Henry J. Kaminski, MD, FAAN
10:20 AM - 10:30 AM		Questions and Answers
10:30 AM - 10:45 AM		Break
10:45 AM - 11:25 AM		Therapy for Myasthenia Gravis: Balancing Efficacy and Costs Donald B. Sanders, MD, FAAN
11:25 AM - 11:55 AM		Case Studies in Neuromuscular Transmission Disorders Janice M. Massey, MD, FAAN
11:55 AM - 12:35 PM		Distinguishing Features of Congenital Myasthenic Syndromes C. M. Harper, MD, FAAN
12:35 PM - 12:45 PM		Questions and Answers

Faculty Disclosures
C. M. Harper, MD, FAAN	Dr. Harper has nothing to disclose.
Henry J. Kaminski, MD, FAAN	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Janice M. Massey, MD, FAAN	Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Donald B. Sanders, MD, FAAN	Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Ted M. Burns, MD	Dr. Burns has nothing to disclose.

��ɫ��

��ɫ��